TABLE 2 from First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, As Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors

Mark Yarchoan,John D. Powderly,Bruno R. Bastos,Thomas B. Karasic,Oxana V. Crysler,Pamela N. Munster,Meredith A. McKean,Leisha A. Emens,Yvonne M. Saenger,Yasser Ged,Robert Stagg,Steven Smith,Chan C. Whiting,Anne Moon,Peppi Prasit,Yonchu Jenkins,Nathan Standifer,Thomas W. Dubensky,Sam H. Whiting,Susanna V. Ulahannan

crossref（2024）

引用 0|浏览14
暂无评分
摘要
Treatment-related treatment-emergent AEs by preferred term in ≥1 patient, any grade and grade 3
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要